| Title |
Cardiac tissue engineering and regeneration using cell-based therapy
|
|---|---|
| Published in |
Stem cells and cloning advances and applications, May 2015
|
| DOI | 10.2147/sccaa.s54204 |
| Pubmed ID | |
| Authors |
Mohammad T Alrefai, Divya Murali, Arghya Paul, Khalid M Ridwan, John M Connell, Dominique Shum-Tim |
| Abstract |
Stem cell therapy and tissue engineering represent a forefront of current research in the treatment of heart disease. With these technologies, advancements are being made into therapies for acute ischemic myocardial injury and chronic, otherwise nonreversible, myocardial failure. The current clinical management of cardiac ischemia deals with reestablishing perfusion to the heart but not dealing with the irreversible damage caused by the occlusion or stenosis of the supplying vessels. The applications of these new technologies are not yet fully established as part of the management of cardiac diseases but will become so in the near future. The discussion presented here reviews some of the pioneering works at this new frontier. Key results of allogeneic and autologous stem cell trials are presented, including the use of embryonic, bone marrow-derived, adipose-derived, and resident cardiac stem cells. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 161 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 2 | 1% |
| Brazil | 1 | <1% |
| Singapore | 1 | <1% |
| Russia | 1 | <1% |
| Poland | 1 | <1% |
| Unknown | 155 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 39 | 24% |
| Student > Bachelor | 37 | 23% |
| Student > Master | 21 | 13% |
| Researcher | 18 | 11% |
| Student > Postgraduate | 6 | 4% |
| Other | 12 | 7% |
| Unknown | 28 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Engineering | 30 | 19% |
| Medicine and Dentistry | 27 | 17% |
| Agricultural and Biological Sciences | 22 | 14% |
| Biochemistry, Genetics and Molecular Biology | 20 | 12% |
| Materials Science | 8 | 5% |
| Other | 22 | 14% |
| Unknown | 32 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 November 2023.
All research outputs
#5,340,716
of 25,584,565 outputs
Outputs from Stem cells and cloning advances and applications
#17
of 67 outputs
Outputs of similar age
#61,827
of 279,338 outputs
Outputs of similar age from Stem cells and cloning advances and applications
#2
of 3 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 67 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 279,338 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.